ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

REBECCA MAGBAG MD

5901 PALISADE AVE THE HEBREW HOME FOR THE AGED AT RIVERDALE

Riverdale | New York | 10471

(718) 581-1200

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,053Medicare Part D Prescriptions Filled, Including Refills

Rank: 831 out of 5176

$445K Total Retail Price of All Prescriptions

Rank: 1434 out of 5176

217 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 217 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,976 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
DONEPEZIL HCL 399 399 1 28
SIMVASTATIN 391 391 2 1
LEVOTHYROXINE SODIUM 331 331 3 4
LISINOPRIL 323 323 4 5
METOPROLOL TARTRATE 292 292 5 6
QUETIAPINE FUMARATE 280 280 6 75
MIRTAZAPINE 262 250 7 45
AMLODIPINE BESYLATE 251 251 8 2
FUROSEMIDE 249 249 9 8
ALBUTEROL SULFATE 230 230 10 99
NAMENDA 199 199 11 47
SERTRALINE HCL 186 186 12 30
IPRATROPIUM BROMIDE 182 182 13 135
OMEPRAZOLE 177 177 14 3
POLYETHYLENE GLYCOL 3350 142 140 15 74
OLANZAPINE 139 139 16 140
SEROQUEL 128 128 17 166
CITALOPRAM HBR 125 125 18 31
RISPERIDONE 125 125 18 78
TRAZODONE HCL 123 104 20 71
RANITIDINE HCL 119 119 21 36
LOVASTATIN 111 108 22 46
JANUVIA 110 110 23 25
BRIMONIDINE TARTRATE 109 109 24 244
ATORVASTATIN CALCIUM 99 99 25 9
ATENOLOL 97 97 26 12
DIVALPROEX SODIUM 89 89 27 104
ALENDRONATE SODIUM 88 88 28 18
VALPROIC ACID 83 83 29 195
LANTUS 82 82 30 66
METFORMIN HCL 80 80 31 7
LEVETIRACETAM 76 61 32 92
MONOJECT INSULIN SYRINGE 70 70 33 520
TRAVATAN Z 70 70 33 234
METOPROLOL SUCCINATE 69 69 35 11
HALOPERIDOL 68 68 36 145
TAMSULOSIN HCL 62 62 37 20
CARBIDOPA-LEVODOPA 59 59 38 98
HYDROCHLOROTHIAZIDE 58 58 39 10
LATANOPROST 57 57 40 185
DIGOXIN 56 56 41 56
CHLORHEXIDINE GLUCONATE 56 56 41 202
LOSARTAN POTASSIUM 55 55 43 14
GABAPENTIN 55 55 43 21
MUPIROCIN 54 54 45 182
ENALAPRIL MALEATE 53 53 46 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.